Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Olivier Toupance"'
Autor:
Jean-Philippe Bertocchio, Coralie Barbe, Sylvie Lavaud, Olivier Toupance, Pierre Nazeyrollas, Frederic Jaisser, Philippe Rieu
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153635 (2016)
Animal studies have highlighted the role of vascular mineralocorticoid receptor during Cyclosporine A-induced nephrotoxicity. Mineralocorticoid receptor antagonists could improve kidney survival but are not commonly used during renal impairment and i
Externí odkaz:
https://doaj.org/article/ecf556abdf8340af94d4dd5c970c843e
Autor:
Olivier Toupance, Philippe Rieu, Frederic Jaisser, Coralie Barbe, Sylvie Lavaud, Pierre Nazeyrollas, Jean-Philippe Bertocchio
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0153635 (2016)
PLoS ONE
PLoS ONE
Background Animal studies have highlighted the role of vascular mineralocorticoid receptor during Cyclosporine A-induced nephrotoxicity. Mineralocorticoid receptor antagonists could improve kidney survival but are not commonly used during renal impai
Autor:
Pierre Merville, Anne-Elisabeth Heng, Georges Mourad, Antoine Thierry, Patrick Lepogamp, Christophe Legendre, Stéphane Quéré, Nassim Kamar, Yannick Le Meur, Arara Terpereau, Bruno Moulin, Guy Touchard, Michèle Kessler, Olivier Toupance, Matthias Büchler, Kamel Chaouche-Teyara, Gabriel Choukroun, Florence Villemain
Publikováno v:
Nephrology Dialysis Transplantation. 27:3651-3659
Background. Short-term intensified dosing using enteric-coated mycophenolate sodium (EC-MPS) reduces rejection after kidney transplantation without compromising safety and may facilitate steroid avoidance. Methods. In a 6-month, multicentre open-labe
Autor:
Sophie Caillard, B. Hurault de Ligny, Ramzi Abou-Ayache, Pierre-François Westeel, Y. Le Meur, G. Sinnasse-Raymond, P. Le Pogamp, Olivier Toupance, Isabelle Etienne, Mathias Büchler, Guy Touchard
Publikováno v:
Transplantation Proceedings. 43:2630-2635
Cytomegalovirus (CMV) infections posttransplant may increase the risk of acute rejection, graft failure, patient death, opportunistic infections, malignancy, diabetes, and cardiovascular complications. ECTAZ, a multicenter, randomized trial compared
Autor:
Bruno Hurault de Ligny, Didier Ducloux, Philippe Rieu, Marc Ladrière, Jean-Marc Chalopin, Cécile Courivaud, Bruno Moulin, Luc Frimat, Olivier Toupance, Sylvie Chauve, Sophie Caillard, Jean-Philippe Ryckelynck, Amir Kazory
Publikováno v:
Clinical Transplantation. 25:794-799
Post-transplant diabetes mellitus (PTDM) is a well-known complication in renal transplant recipients (RTRs). While a number of risk factors for PTDM have been identified, the potential impact of pre-transplant dialysis modality on subsequent developm
Autor:
Stéphane Quéré, Christophe Legendre, Robert Genin, Olivier Toupance, Pierre François Westeel, Lionel Rostaing, Bruno Moulin, François Bayle, Fabienne Di Giambattista, François Berthoux, Marie-Christine Moal, Niloufar Kossari, Nicole Lefrançois, Denis Glotz, Bernard Charpentier, Jacques Dantal, Jean-Philippe Rerolle, Elisabeth Cassuto, Pierre Merville
Publikováno v:
Transplant International. 23:1084-1093
Summary Immediate or early use of proliferation signal inhibitor (PSI)/mammalian target of rapamycin (mTOR) inhibitor therapy can avoid high exposure to calcineurin inhibitors but concerns exist relating to the risk of delayed graft function (DGF) an
Autor:
Bruno Hurault de Ligny, Jacques Benichou, Pierre-François Westeel, Pierre Marquet, Olivier Toupance, Michel Godin, Yannick Le Meur, Antoine Thierry, Marie-France Hellot, Azmi Al Najjar, Isabelle Etienne, Arnaud François
Publikováno v:
Nephrology Dialysis Transplantation. 25:3096-3106
Background. Although cyclosporine maintenance therapy reduces the risk of acute rejection and increases short-term graft survival in renal transplant recipients, its associated nephrotoxicity increases the risk of chronic graft dysfunction. The dose
Autor:
Guillaume Hoizey, Khaled Benkali, Jean-Philippe Rerolle, Pierre Marquet, Olivier Toupance, Aurélie Prémaud, Alain Turcant, Florence Villemain, Annick Rousseau, Yannick Le Meur, Nicolas Picard
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, Springer Verlag, 2009, 48 (12), pp.805-816. ⟨10.2165/11318080-000000000-00000⟩
Clinical Pharmacokinetics, Springer Verlag, 2009, 48 (12), pp.805-816. ⟨10.2165/11318080-000000000-00000⟩
Objectives: The aims of this study were (i) to investigate the population pharmacokinetics of tacrolimus in renal transplant recipients, including the influence of biological and pharmacogenetic covariates; and (ii) to develop a Bayesian estimator ab
Autor:
Yvon Lebranchu, Y. Le Meur, C. Hayem, B. Moulin, Vannary Meas-Yedid, P. Le Pogamp, Olivier Toupance, Denis Glotz, J. C. Olivo Marin, Aude Servais, C. Presne, De Ligny B. Hurault, Eric Thervet, Isabelle Etienne, Antoine Thierry
Publikováno v:
American Journal of Transplantation. 9:2552-2560
Conversion from cyclosporine (CsA) to sirolimus at week 12 after kidney transplantation is associated with a significant improvement in renal function. The aim of this analysis was to investigate the effect of this conversion on interstitial fibrosis
Autor:
Laetitia, Albano, François, Berthoux, Marie-Christine, Moal, Lionel, Rostaing, Christophe, Legendre, Robert, Genin, Olivier, Toupance, Bruno, Moulin, Pierre, Merville, Jean-Philippe, Rerolle, François, Bayle, Pierre François, Westeel, Denis, Glotz, Niloufar, Kossari, Nicole, Lefrançois, Bernard, Charpentier, Anne-Sandrine, Blanc, Fabienne, Di Giambattista, Jacques, Dantal
Publikováno v:
Transplantation. 88:69-76
Background Concerns about delayed graft function (DGF) and wound healing complications with sirolimus has led to suggestions that everolimus introduction could be delayed after transplantation. Methods In a prospective, multicenter, open-label study,